Kraft Heinz, Clorox and Hershey Look Cheap, but the Risks Differ

Morningstar sees Kraft Heinz, Clorox and Hershey as three of the widest valuation gaps in consumer staples, with the stocks trading roughly 40%, 45% and 30% below its fair-value estimates. That makes the group look tempting after a weak year. It does not make the three situations equivalent.

The common problem is volume. Consumers have absorbed years of food inflation and are trading down, while freight and warehousing costs are squeezing manufacturers. The source report says organic volumes across packaged-goods companies have slipped since early 2023, a reversal from the growth seen before the recent inflation cycle.

Kraft Heinz offers the highest immediate income, with a yield near 7%, and management has redirected money toward brand investment after abandoning a planned separation. Yet its second-quarter sales still fell 1.4%, and the company expects 2026 constant-currency adjusted operating income to decline 16% to 18%. A dividend can remain covered while the business behind it weakens.

Clorox has a different setup. Hidden Valley and Glad are gaining share, but fiscal 2026 free cash flow of $405 million did not cover $602 million of dividends. Management calls that mismatch temporary and guides to 3.5% to 4.5% organic sales growth and adjusted EPS of $5.70 to $6.00 in fiscal 2027. Investors therefore need operating improvement, not merely a cheaper multiple.

Hershey's discount rests on confidence that pricing, innovation and marketing can offset cocoa costs and shifting consumer preferences. That is a cleaner brand-strength thesis, but it still depends on margins and volumes stabilizing.

A low price relative to an analyst estimate is an invitation to investigate, not proof that the market is wrong. The useful distinction is what must improve: Kraft Heinz needs a sales and profit reset, Clorox needs cash conversion to catch up with its dividend, and Hershey needs brand power to outrun input pressure.